Renal Pathology in Fabry Disease
- 1 June 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 13 (suppl_2) , S134-S138
- https://doi.org/10.1097/01.asn.0000016684.07368.75
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Fabry Disease (α-Galactosidase A Deficiency)Published by Elsevier ,2001
- Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry diseaseProceedings of the National Academy of Sciences, 2000
- The role of the podocyte in glomerulosclerosisCurrent Opinion in Nephrology and Hypertension, 1999
- AUTHOR INDEXTransplantation, 1991
- The properties of α-galactosidase remaining in kidney and liver of patients with Fabry's diseaseChemistry and Physics of Lipids, 1974